REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 31 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $51,000 | -33.8% | 99,691 | +20.7% | 0.00% | – |
Q4 2018 | $77,000 | -47.6% | 82,605 | 0.0% | 0.00% | – |
Q3 2018 | $147,000 | +26.7% | 82,605 | 0.0% | 0.00% | – |
Q2 2018 | $116,000 | -0.9% | 82,605 | +7.0% | 0.00% | – |
Q1 2018 | $117,000 | +20.6% | 77,213 | +61.3% | 0.00% | – |
Q4 2017 | $97,000 | -16.4% | 47,859 | 0.0% | 0.00% | – |
Q3 2017 | $116,000 | -15.3% | 47,859 | 0.0% | 0.00% | – |
Q2 2017 | $137,000 | – | 47,859 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CVI Holdings, LLC | 1,547,837 | $1,439,000 | 3.20% |
Anson Funds Management LP | 607,113 | $565,000 | 0.33% |
Benin Management CORP | 14,300 | $13,000 | 0.01% |
NORTHWEST WEALTH MANAGEMENT, LLC | 4,000 | $4,000 | 0.00% |
WEDBUSH SECURITIES INC | 25,500 | $24,000 | 0.00% |
Virtu Financial LLC | 45,555 | $42,000 | 0.00% |
Northeast Financial Consultants Inc | 15,000 | $14,000 | 0.00% |
Capital Advisory Group Advisory Services, LLC | 900 | $1,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 103,100 | $96,000 | 0.00% |
FRONTIER INVESTMENT MGMT CO | 20,000 | $19,000 | 0.00% |